Emergent BioSolutions and SIGA Technologies were both failing companies before all this began, and now they suddenly hold a monopoly in the U.S. market for smallpox drugs – how convenient.

Share prices in both companies have risen substantially ever since monkeypox started appearing in the news cycle. Emergent's stock climbed 12 percent the other day while SIGA's soared by 17.1 percent.

"For these companies, the monkeypox fears are a godsend, specifically for SIGA, which produces a smallpox treatment, known by its brand name TPOXX," writes Whitney Webb for The Defender. "It is SIGA's only product."

It turns out that Ron Perelman is behind SIGA, which is part of his powerful empire of company holdings. Perelman, as you may recall, has troubling ties to pedophile Jeffrey Epstein, as well as to the Clinton crime family and the Democrat Party.